|CANF -- Israel Stock|| |
ILS 234.30 1.30 0.56%
Analysis of Can Fite manpower and management performance can provide insight into Can Fite stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Can Fite BioPharma future performance. Check also Trending Equities
Can Fite Management Effectiveness
The company has return on total asset (ROA)
of (34.8) %
which means that it has lost $34.8 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (73.21) %
meaning that it generated substantial loss on money invested by shareholders.
Can Fite Stakeholders
Can Fite employes about 7 people. The company is managed by 6 executives with total tenure of roughly 71 years, averanging almost 11.0 years of service per executive having 1.0 employee per reported executive.
|Revenue Per Employee||200 K|
|Revenue Per Executive||233.3 K|
|Net Loss Per Employee||707.1 K|
|Net Loss Per Executive||825 K|
Check also Trending Equities
. Please also try Positions Ratings
module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.